M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
- ►ajcn.org D Giugliano, A Ceriello, K Esposito - American Journal of Clinical Nutrition, 2008 - Am Soc Nutrition Islet dysfunction and peripheral insulin resistance are both present in type 2
diabetes and are both necessary for the development of hyperglycemia. In both
type 1 and type 2 diabetes, large, prospective clinical studies have shown ... Cited by 30 - Related articles - BL Direct - All 4 versions
MS Rendell, L Jovanovic - Metabolism, 2006 - Elsevier In healthy individuals, blood glucose levels in the fasting state are maintained
by the continuous basal-level insulin secretion. After a meal, the rise in
postprandial glucose (PPG) is controlled by the rapid pancreatic release of ... Cited by 29 - Related articles - All 12 versions
A Ceriello, J Davidson, M Hanefeld, L Leiter, … - Nutrition, Metabolism and Cardiovascular Diseases, 2006 - Elsevier Type 2 diabetes is characterised by a gradual decline in insulin secretion in
response to nutrient loads; hence, it is primarily a disorder of postprandial
glucose (PPG) regulation. However, physicians continue to rely on fasting ... Cited by 30 - Related articles - All 4 versions
R Assaloni, R Ros, L Quagliaro, L Piconi, A … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 1919–1924 DOI 10.1007/s00125-005-1849-5 ARTICLE
R. Assaloni . R. Da Ros . L. Quagliaro . L. Piconi . A. Maier . G. Zuodar . ... Cited by 24 - Related articles - BL Direct - All 3 versions
SE Inzucchi, DK McGuire - Circulation, 2008 - Am Heart Assoc This is the second of a 2-part series focusing on newer therapies for type 2
diabetes and their cardiovascular implications. In the first segment, we
reviewed the thiazolidinediones, highlighting emerging data concerning ... Cited by 21 - Related articles - All 6 versions
D Singh-Franco, G Robles, D Gazze - Clinical Therapeutics, 2007 - Elsevier Pramlintide is administered subcutaneously in the abdominal area or thigh
immediately before each main meal to achieve maximal reductions in post-prandial
glucose excursions. Its C max is reached within 20 minutes, and its t 1/2 ... Cited by 16 - Related articles - All 2 versions
TS Burgert, J Dziura, C Yeckel, SE Taksali, … - International Journal of Obesity, 2005 - nature.com MA was defined as a UACR between 2.0 and 20 mg/mmol. Subjects with gross
proteinuria (UACR>20 mg/mmol) were excluded from the study. Analyses were
performed to assess the relationship of MA and markers of CV risk, ... Cited by 14 - Related articles - BL Direct - All 5 versions
TMS Wolever, 2006 - books.google.com The GIycaemic Index A Physiological Classification of Dietary Carbohydrate ...
The Glycaemic Index A Physiological Classification of Dietary Carbohydrate
Thomas MS Wolever Department of Nutritional Sciences University of Toronto ... Cited by 12 - Related articles - All 3 versions
